Abstract:Abstract Background Breast cancer is the most prevalent and among the most deadly cancers in females. Patients with breast cancer have highly variable survival lengths, indicating a need to identify prognostic biomarkers for personalized diagnosis and treatment. With the development of new technologies such as next-generation sequencing, multi-omics information are becoming available for a more thorough evaluation of a patient’s condition. In this study, we aim to improve breast cancer overall survival prediction by integrating multi-omics data (e.g., gene expression, DNA methylation, miRNA expression, and copy number variations (CNVs)). Methods Motivated by multi-view learning, we propose a novel strategy to integrate multi-omics data for breast cancer survival prediction by applying complementary and consensus principles. The complementary principle assumes each -omics data contains modality-unique information. To preserve such information, we develop a concatenation autoencoder (ConcatAE) that concatenates the hidden features learned from each modality for integration. The consensus principle assumes that the disagreements among modalities upper bound the model errors. To get rid of the noises or discrepancies among modalities, we develop a cross-modality autoencoder (CrossAE) to maximize the agreement among modalities to achieve a modality-invariant representation. We first validate the effectiveness of our proposed models on the MNIST simulated data. We then apply these models to the TCCA breast cancer multi-omics data for overall survival prediction. Results For breast cancer overall survival prediction, the integration of DNA methylation and miRNA expression achieves the best overall performance of 0.641 ± 0.031 with ConcatAE, and 0.63 ± 0.081 with CrossAE. Both strategies outperform baseline single-modality models using only DNA methylation (0.583 ± 0.058) or miRNA expression (0.616 ± 0.057). Conclusions In conclusion, we achieve improved overall survival prediction performance by utilizing either the complementary or consensus information among multi-omics data. The proposed ConcatAE and CrossAE models can inspire future deep representation-based multi-omics integration techniques. We believe these novel multi-omics integration models can benefit the personalized diagnosis and treatment of breast cancer patients.

Improving Model Performance on the Stratification of Breast Cancer Patients by Integrating Multiscale Genomic Features

Integrating Multi-scale Gene Features for Cancer Diagnosis.

A multimodal machine learning model for the stratification of breast cancer risk

Stratification Of Breast Cancer By Integrating Gene Expression Data And Clinical Variables

Integrative analysis of pathological images and multi-dimensional genomic data for early-stage cancer prognosis.

Integrated Machine Learning Algorithms for Stratification of Patients with Bladder Cancer

Deep learning based feature-level integration of multi-omics data for breast cancer patients survival analysis

Exploring Prognostic Gene Factors in Breast Cancer via Machine Learning

Identifying Oncogenes As Features for Clinical Cancer Prognosis by Bayesian Nonparametric Variable Selection Algorithm

Integrating Somatic Mutations for Breast Cancer Survival Prediction Using Machine Learning Methods

Single-cell omics and machine learning integration to develop a polyamine metabolism-based risk score model in breast cancer patients

Integrating Biological Knowledge with Gene Expression Profiles for Survival Prediction of Cancer

Multi-scale supervised clustering-based feature selection for tumor classification and identification of biomarkers and targets on genomic data

Identification of Prognostic and Heterogeneous Breast Cancer Biomarkers Based on Fusion Network and Multiple Scoring Strategies.

Integrating Single-Cell and Bulk Expression Data to Identify and Analyze Cancer Prognosis-Related Genes

Predicting features of breast cancer with gene expression patterns

Uncovering the Prognostic Gene Signatures for the Improvement of Risk Stratification in Cancers by Using Deep Learning Algorithm Coupled with Wavelet Transform

Nature-inspired Multiobjective Patient Stratification from Cancer Gene Expression Data

Combining Multidimensional Genomic Measurements for Predicting Cancer Prognosis: Observations from TCGA

Integrating of Genomic and Transcriptomic Profiles for the Prognostic Assessment of Breast Cancer

Network Based Stratification of Major Cancers by Integrating Somatic Mutation and Gene Expression Data.